Gene · 3490
Papers3,920
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
141 to 160 of 3,920
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Influence of Stress-Induced Senescence on the Secretome of Primary Mesenchymal Stromal Cells. | Biomolecules | 2025 | 41463387 | PubTator, text mining | PubMed |
| Identification the Tumor Mechanics-Related Biomarkers in Gastric Cancer Patients Based on Bioinformatics and Machine Learning. | Int J Gen Med | 2025 | 41438119 | PubTator, text mining | PubMed |
| Integrative Analysis of eQTL Genes Reveals Key Biomarkers and Mechanisms for Early Diagnosis of Pancreatic Ductal Adenocarcinoma. | Cancer Inform | 2025 | 41415264 | PubTator, text mining | PubMed |
| Novel Kidney Biomarkers and Antibiotics-Induced Acute Kidney Injury: A Practical Assessment of Current and Future Applications. | Clin Transl Sci | 2025 | 41414868 | PubTator, text mining | PubMed |
| Urine Tubular Biomarkers Are Associated With Natriuresis in Patients With Acute Heart Failure. | J Am Heart Assoc | 2025 | 41378503 | PubTator, text mining | PubMed |
| Role of Urinary Biomarkers TIMP-2 and IGFBP7 in Predicting Acute Kidney Injury in Critically Ill Trauma Patients: A Prospective Observational Study. | Indian J Crit Care Med | 2025 | 41368450 | PubTator, text mining | PubMed |
| Optimizing pediatric AKI diagnosis: a patient-tailored meta-analysis of urinary TIMP-2/IGFBP7 performance across clinical scenarios and assay platforms. | Front Pediatr | 2025 | 41332898 | PubTator, text mining | PubMed |
| Renal insulin-like growth factor binding-protein 7 is a critical promoter of progressive diabetic kidney disease. | Nat Commun | 2025 | 41326394 | PubTator, text mining | PubMed |
| Evaluation of a Novel Biomarker Panel for Acute Kidney Injury Following Endovascular Aortic Repair. | Int J Mol Sci | 2025 | 41303638 | PubTator, text mining | PubMed |
| Effects of Empagliflozin in Heart Failure Patients with Type 2 Diabetes: A Biomarker Perspective. | Exp Clin Endocrinol Diabetes | 2025 | 41290014 | PubTator, text mining | PubMed |
| Proteomic biomarkers and biological pathways associated with atrial fibrillation in heart failure patients with reduced ejection fraction. | Heart Rhythm O2 | 2025 | 41280530 | PubTator, text mining | PubMed |
| Urine Microscopy: The Enduring Value of a Classic Test. | Kidney360 | 2025 | 41264406 | PubTator, text mining | PubMed |
| IGFBP7 and CCT2 are novel lactylation-driven mediators of endothelial-to-mesenchymal transition in idiopathic pulmonary fibrosis. | Funct Integr Genomics | 2025 | 41261179 | PubTator, text mining | PubMed |
| Long-Term Effects of Semaglutide and Sitagliptin on Circulating IGFBP-1, IGFBP-3 and IGFBP-rp1: Results from a One-Year Study in Type 2 Diabetes. | Int J Mol Sci | 2025 | 41226444 | PubTator, text mining | PubMed |
| Identifying autophagy-related biomarkers in the treatment of renal interstitial fibrosis with Shen Fukang through network pharmacology. | Medicine (Baltimore) | 2025 | 41204488 | PubTator, text mining | PubMed |
| High-Throughput Tear Proteomics Reveals Multi-Faceted Signatures of Thyroid Eye Disease. | Invest Ophthalmol Vis Sci | 2025 | 41196132 | PubTator, text mining | PubMed |
| Integrating Novel Biomarkers into Clinical Practice: A Practical Framework for Diagnosis and Management of Cardiorenal Syndrome. | Life (Basel) | 2025 | 41157213 | PubTator, text mining | PubMed |
| Acute Kidney Injury Biomarkers in Marathon Runners: Systematic Review and Meta-Analysis. | Medicina (Kaunas) | 2025 | 41155766 | PubTator, text mining | PubMed |
| Hypohydration augments the acute increase in urinary biomarkers of kidney injury following the 100-mile Western States Endurance Run. | J Appl Physiol (1985) | 2025 | 41115071 | PubTator, text mining | PubMed |
| Biomarkers of organ stress and injury following the Boston Marathon. | J Appl Physiol (1985) | 2025 | 41101781 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3490/papers?page=8